APP and Alzheimer disease: In addition, Bakshi et al. reported that knockout of C-X-C chemokine receptor type 2 (CXCR2) inhibited Aβ production in the APP/PS1 model of AD, further elucidating the mechanism of Aβ production in AD (Bakshi et al., 2011).